Company / Current Assets
iBio, Inc. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$9.7M
FY2025
5-year range
$9.7M / $104.6M
FY2021-FY2025
Trend
-63.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has fluctuated over the past 10 years, ranging from $5M in FY2019 to $105M in FY2021.
Based on SEC 10-K filings.
$10M in FY2025 with a 5-year CAGR of -30.9%.
Declined from $26M to $10M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -40.0%
- 5-Year CAGR
- -30.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -30.9%, indicating a declining trend.
- In FY2025, current assets decreased 63.0% year-over-year.
- Peak current assets was recorded in FY2021.
- Lowest current assets in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -1.36 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.7M | -63.0% |
| FY2024 | $26.3M | +0.0% |
| FY2023 | $26.3M | -41.7% |
| FY2022 | $45.1M | -56.9% |
| FY2021 | $104.6M | +69.4% |
| FY2020 | $61.7M | +1184.3% |
| FY2019 | $4.8M | -70.5% |
| FY2018 | $16.3M | +90.0% |
| FY2017 | $8.6M | -64.1% |
| FY2016 | $23.9M | +136.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026